Titolo	Data di pubblicazione	Autore(i)
1	Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study	2010	Quaglino P; Marenco F; Osella-Abate S; Cappello N; Ortoncelli M; Salomone B; Fierro MT; Savoia P; Bernengo MG.
2	Virus di Epstein-Barr e linfomi primitivi cutanei: valutazione della carica virale mediante PCR quantitativa-competitiva (QC-PCR) su biopsia.	2006	Bergallo M; Costa C; Novelli M; Ponti R; Fierro MT; Margio S; Bernengo MG; Merlino C; Cavallo R.
3	Ultrasonography in the pathway to an optimal standard of care of hidradenitis suppurativa: the Italian Ultrasound Working Group experience	2019	Lacarrubba F.; Dini V.; Napolitano M.; Venturini M.; Caposiena Caro D.R.; Molinelli E.; Passoni E.; Monfrecola G.; Argenziano G.; Berti E.; Bianchi L.; Calzavara Pinton P.; Cannavo S.P.; Costanzo A.; Donini M.; Fabbrocini G.; Fierro M.T.; Micali G.; Offidani A.; Parodi A.; Patrizi A.; Pellacani G.; Peris K.; Pimpinelli N.; Potenza C.; Romanelli M.; Rongioletti F.; Solivetti F.
4	Tyrosinase expression in the peripheral blood of stage III melanoma patients is associated with a poor prognosis: a clinical follow-up study of 110 patients.	2003	OSELLA-ABATE S; SAVOIA P; QUAGLINO P; FIERRO MT; LEPORATI C; ORTONCELLI M; M. BERNENGO
5	Treatment of Sézary Syndrome by anti-CD52 monoclonal antibodt Alemtuzumab: clinical and immunological findings in 24 patients	2010	Bernengo MG; Quaglino P; Marenco F; Novelli M; Comessatti A; Savoia P; Fierro MT
6	Treatment of metastatic melanoma: a multidisciplinary approach	2017	Fava, Paolo; Astrua, Chiara; Sanlorenzo, Martina; Ribero, Simone; Brizio, Matteo; Filippi, Andrea R; Marra, Elena; Picciotto, Franco; Sangiolo, Dario; Carnevale-Schianca, Fabrizio; Aglietta, Massimo; Sandrucci, Sergio; Ricardi, Umberto; Caliendo, Virginia; Quaglino, Pietro; Fierro, Maria T
7	Treatment of hairy-cell leukaemia with alpha-interferon (alpha-IFN).	1988	LAURIA F ;FOÀ R ;RASPADORI D ;ZINZANI PL ;BUZZI M ;FIERRO MT ;BONFERRONI M ;FANIN R ;GALLIZIA C ;MICHIELI MG
8	Treatment of advanced mycosis fungoides/Sézary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy.	2004	QUAGLINO P; FIERRO M; ROSSOTTO GL; SAVOIA P; BERNENGO MG
9	A traveller's wart: tungiasis	2018	Fava, Paolo; Astrua, Chiara; Brizio, Matteo; Cavaliere, Giovanni; Senetta, Rebecca; Fierro, Maria Teresa; Quaglino, Pietro
10	Time course and pattern of first relapse in stage I-II primary cutaneous melanoma: a multivariate analysis of disease-free survival in 3,174 patients followed-up at the Turin Melanoma Centre from 1975 to 2004	2005	BERNENGO MG; QUAGLINO P; CAPPELLO N; FIERRO MT; DOVEIL GC; MACRIP G; OSELLA-ABATE S; PERONI A; LISA F; SAVOIA P
11	Thymopentin in Sézary syndrome.	1992	M. BERNENGO; APPINO A; BERTERO M; NOVELLI M; FIERRO MT; DOVEIL GC; LISA F.
12	Therapy for metastatic melanoma: effective combination of dacarbazine, carmustine, cisplatin and tamoxifen.	1993	M.T. FIERRO; M. BERTERO; M. NOVELLI; A. APPINO; G.C. DOVEIL; S. COLONNA; M.G. BERNENGO
13	Therapy and prognostic factors in Sezary syndrome patients.	1999	Quaglino P; Fierro MT; Savoia P; Lisa F; De Matteis A; Doveil GC; Bernengo MG
14	Therapeutic hotline. A rare vandetanib-induced photo-allergic drug eruption.	2010	Fava P; Quaglino P; Fierro MT; Novelli M; Bernengo MG.
15	Therapeutic approaches in advanced mycosis fungoides and Sezary Sindrome. A 30-year single institution experience	2009	Pietro Quaglino; Paolo Fava; Federica Marenco; Tiziana Nardò; Paola Savoia; Maria Teresa Fierro; Maria Grazia Bernengo
16	The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells.	2001	BERNENGO MG; NOVELLI M; QUAGLINO P; LISA F; DE MATTEIS A; SAVOIA P; CAPPELLO N; FIERRO MT
17	The integrin heterodimer 3ß1 is expressed in skin but not in peripheral blood Sézary cells.	1991	Savoia P; Novelli M; Fierro MT; Cremona O; Marchisio PC; Bernengo MG
18	The association of etoposide, idarubicin, cyclophosphamide, vincristine, prednisone and bleomycin (VICOP-B) in the treatment of advanced cutaneous T-cell lymphoma (CTCL).	1995	Bernengo MG; Doveil GC; Fierro MT; Quaglino P; Savoia P:
19	Th1, Th2, Th17 and Treg expression in cutaneous T-cell lymphoma patients: modulation of master gene targets.	2013	Quaglino P; Ponti R; Bergallo M; Fierro MT; Fava P; Barberio E; Terlizzi ME; Astegiano S; Bernengo MG.
20	TERT Promoter Mutations are Associated with Visceral Spreading in Melanoma of the Trunk	Being printed	Simona Osella-Abate, Luca Bertero, Rebecca Senetta, Sara Mariani, Francesco Lisa, Vittoria Coppola, Jasna Metovic, Barbara Pasini, Susana Puig, Maria Teresa Fierro, Esperanza Manrique-Silva, Rajiv Kumar, Eduardo Nagore, Paola Cassoni, Simone Ribero.